Palo Alto Medical Foundation-Camino Division — Mountain View, California

Palo Alto Medical Foundation-Camino Division is a clinical research site located in Mountain View, California, United States 94040.

Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.

Palo Alto Medical Foundation-Camino Division has participated in 153 clinical trials with 82 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mountain View

Browse all research sites in California · View every site in Mountain View

Sponsor Feasibility Report

Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palo Alto Medical Foundation-Camino Division?

Palo Alto Medical Foundation-Camino Division has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palo Alto Medical Foundation-Camino Division conducted?

Palo Alto Medical Foundation-Camino Division has 153 clinical trials on record, with 82 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Palo Alto Medical Foundation-Camino Division accredited by Crixeo Clinical Trials?

Palo Alto Medical Foundation-Camino Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palo Alto Medical Foundation-Camino Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.